{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:45:56Z","timestamp":1787499956112,"version":"build-2736575974"},"reference-count":164,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12012-025-10079-3","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T11:27:55Z","timestamp":1766575675000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Multimodal Therapeutic Strategies Targeting BCAA Metabolism in Diabetic Cardiomyopathy: A Path to Cardioprotection"],"prefix":"10.1007","volume":"26","author":[{"given":"Shewale","family":"Chetana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4166-3380","authenticated-orcid":false,"given":"Barve","family":"Kalyani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"issue":"1","key":"10079_CR1","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/s41420-023-01553-4","volume":"9","author":"JL Huo","year":"2023","unstructured":"Huo, J. L., Feng, Q., Pan, S., Fu, W. J., Liu, Z., & Liu, Z. (2023). Diabetic cardiomyopathy: Early diagnostic biomarkers, pathogenetic mechanisms, and therapeutic interventions. Cell Death Discovery, 9(1), 256.","journal-title":"Cell Death Discovery"},{"issue":"1","key":"10079_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","volume":"138","author":"NH Cho","year":"2018","unstructured":"Cho, N. H., Shaw, J. E., Karuranga, S., Huang, Y.,da Fernandes R., Ohlrogge A. W., & Malanda, B. (2018). IDF diabetes atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Research and Clinical Practice, 138(1), 271\u2013281. https:\/\/doi.org\/10.1016\/j.diabres.2018.02.023","journal-title":"Diabetes Research and Clinical Practice"},{"key":"10079_CR3","unstructured":"Organization, W. H., & Diabetes (2024). Available\u00a0https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/diabetes"},{"key":"10079_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/2161085","volume":"2019","author":"\u00c9B Rangel","year":"2019","unstructured":"Rangel, \u00c9. B., Rodrigues, C. O., & de S\u00e1, J. R. (2019). Micro- and macrovascular complications in diabetes mellitus: Preclinical and clinical studies. Journal of Diabetes Research, 2019, 1\u20135. https:\/\/doi.org\/10.1155\/2019\/2161085","journal-title":"Journal of Diabetes Research"},{"issue":"9","key":"10079_CR5","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.amjmed.2008.03.046","volume":"121","author":"A Aneja","year":"2008","unstructured":"Aneja, A., Tang, W. H. W., Bansilal, S., Garcia, M. J., & Farkouh, M. E. (2008). Diabetic cardiomyopathy: Insights into pathogenesis, diagnostic challenges, and therapeutic options. American Journal of Medicine, 121(9), 748\u2013757. https:\/\/doi.org\/10.1016\/j.amjmed.2008.03.046","journal-title":"American Journal of Medicine"},{"issue":"3","key":"10079_CR6","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.amjmed.2024.10.026","volume":"138","author":"H Smati","year":"2025","unstructured":"Smati, H.,Qadeer, Y. K., Rodriguez, M., Moras, E., Fonorow, G. C., Issacs, S. D., Marwick T. H., & Krittanawong, C. (2025). Diabetic cardiomyopathy: What clinicians should know. American Journal of Medicine, 138(3), 387\u2013395.","journal-title":"American Journal of Medicine"},{"key":"10079_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1683159","author":"S Prakash","year":"2025","unstructured":"Prakash, S., Choudhury, P., & Bisht, S. (2025). Diabetic cardiomyopathy and COVID-19: Intersecting pathways and amplified cardiovascular risk. Frontiers in Pharmacology. https:\/\/doi.org\/10.3389\/fphar.2025.1683159","journal-title":"Frontiers in Pharmacology"},{"issue":"4","key":"10079_CR8","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/circresaha.117.311586","volume":"122","author":"G Jia","year":"2018","unstructured":"Jia, G., Hill, M. A., & Sowers, J. R. (2018). Diabetic cardiomyopathy. Circulation Research, 122(4), 624\u2013638. https:\/\/doi.org\/10.1161\/circresaha.117.311586","journal-title":"Circulation Research"},{"key":"10079_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2025.133554","author":"C Mann","year":"2025","unstructured":"Mann, C., Braunwald, E., & Zelniker, T. A. (2025). Diabetic cardiomyopathy revisited: The interplay between diabetes and heart failure. International Journal of Cardiology. https:\/\/doi.org\/10.1016\/j.ijcard.2025.133554","journal-title":"International Journal of Cardiology"},{"issue":"6","key":"10079_CR10","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1038\/s42255-024-01036-5","volume":"6","author":"H Wang","year":"2024","unstructured":"Wang, H., Wang, J., Cui, H., Fan, C., Xue, Y., Liu, H., Li, H., Li, J., Li, H., Sun, Y., Wang, W., Song, J., Jiang, C., & Xu, M. (2024). Inhibition of fatty acid uptake by TGR5 prevents diabetic cardiomyopathy. Nature Metabolism, 6(6), 1161\u20131177. https:\/\/doi.org\/10.1038\/s42255-024-01036-5","journal-title":"Nature Metabolism"},{"issue":"11","key":"10079_CR11","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.3390\/cells10113259","volume":"10","author":"QG Karwi","year":"2021","unstructured":"Karwi, Q. G., Sun, Q., & Lopaschuk, G. D. (2021). The contribution of cardiac fatty acid oxidation to diabetic cardiomyopathy severity. Cells, 10(11), 3259. https:\/\/doi.org\/10.3390\/cells10113259","journal-title":"Cells"},{"key":"10079_CR12","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1113\/jp276747","volume":"598","author":"M Nakamura","year":"2019","unstructured":"Nakamura, M., & Sadoshima, J. (2019). Cardiomyopathy in obesity, insulin resistance and diabetes. Journal of Physiology, 598, 2977\u20132993. https:\/\/doi.org\/10.1113\/jp276747","journal-title":"Journal of Physiology"},{"issue":"23","key":"10079_CR13","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1161\/circulationaha.111.060889","volume":"125","author":"A Chokshi","year":"2012","unstructured":"Chokshi, A., Drosatos, K., Cheema, F. H., Ji, R., Khawaja, T., Yu, S.-Q., Kato, T. S., Khan, R. S., Takayama, H., Kn\u00f6ll, R., Milting, H., Chung, C. B., Jorde, U. P., Naka, Y., Mancini, D., Goldberg, I. J., & Schulze, P. C. (2012). Ventricular assist device implantation corrects myocardial lipotoxicity, reverses insulin resistance, and normalizes cardiac metabolism in patients with advanced heart failure. Circulation, 125(23), 2844\u20132853. https:\/\/doi.org\/10.1161\/circulationaha.111.060889","journal-title":"Circulation"},{"issue":"10","key":"10079_CR14","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1194\/jlr.m800147-jlr200","volume":"49","author":"TS Park","year":"2008","unstructured":"Park, T.-S., Hu, Y., Noh, H.-L., Drosatos, K., Okajima, K., Buchanan, J., Tuinei, J., Homma, S., Jiang, X.-C., Abel, E. D., & Goldberg, I. J. (2008). Ceramide is a cardiotoxin in lipotoxic cardiomyopathy. Journal of Lipid Research, 49(10), 2101\u20132112. https:\/\/doi.org\/10.1194\/jlr.m800147-jlr200","journal-title":"Journal of Lipid Research"},{"key":"10079_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.yjmcc.2025.06.013","volume":"206","author":"D Chen","year":"2025","unstructured":"Chen, D., Sindone, A., Huang, M. L. H., Peter, K., & Jenkins, A. J. (2025). Diabetic cardiomyopathy: Insights into pathophysiology, diagnosis and clinical management. Journal of Molecular and Cellular Cardiology, 206, 55\u201369.","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10079_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/5913374","volume":"2022","author":"Z Tang","year":"2022","unstructured":"Tang, Z., Wang, P., Dong, C., Zhang, J., Wang, X., & Pei, H. (2022). Oxidative stress signaling mediated pathogenesis of diabetic cardiomyopathy. Oxidative Medicine and Cellular Longevity, 2022, 1\u20138. https:\/\/doi.org\/10.1155\/2022\/5913374","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"10079_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.750382","author":"H Zheng","year":"2021","unstructured":"Zheng, H., Zhu, H., Liu, X., Huang, X., Huang, A., & Huang, Y. (2021). Mitophagy in diabetic cardiomyopathy: Roles and mechanisms. Frontiers in Cell and Developmental Biology. https:\/\/doi.org\/10.3389\/fcell.2021.750382","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"10079_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-017-0135-z","author":"CMO Volpe","year":"2018","unstructured":"Volpe, C. M. O., Villar-Delfino, P. H., dos Anjos, P. M. F., & Nogueira-Machado, J. A. (2018). Cellular death, Reactive Oxygen Species (ROS) and diabetic complications. Cell Death & Disease. https:\/\/doi.org\/10.1038\/s41419-017-0135-z","journal-title":"Cell Death & Disease"},{"key":"10079_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2017.00519","author":"B Luo","year":"2017","unstructured":"Luo, B., Huang, F., Liu, Y., Liang, Y., Wei, Z., Ke, H., Zeng, Z., Huang, W., & He, Y. (2017). NLRP3 inflammasome as a molecular marker in diabetic cardiomyopathy. Frontiers in Physiology. https:\/\/doi.org\/10.3389\/fphys.2017.00519","journal-title":"Frontiers in Physiology"},{"key":"10079_CR20","doi-asserted-by":"publisher","first-page":"1497352","DOI":"10.3389\/fendo.2024.1497352","volume":"15","author":"P Choudhury","year":"2024","unstructured":"Choudhury, P., Kosuru, R., & Cai, Y. (2024). The complex phenotype of diabetic cardiomyopathy: Clinical indicators and novel treatment targets. Frontiers in Endocrinology, 15, 1497352.","journal-title":"Frontiers in Endocrinology"},{"issue":"1","key":"10079_CR21","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41392-022-00971-7","volume":"7","author":"F Zhang","year":"2022","unstructured":"Zhang, F., Hu, G., Chen, X., Zhang, L., Guo, L., Li, C., Zhao, H., Cui, Z., Guo, X., Sun, F., Song, D., Yan, W., Xia, Y., Wang, S., Fan, M., & Tao, L. (2022). Excessive branched-chain amino acid accumulation restricts mesenchymal stem cell-based therapy efficacy in myocardial infarction. Signal Transduction and Targeted Therapy, 7(1), 171. https:\/\/doi.org\/10.1038\/s41392-022-00971-7","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"8","key":"10079_CR22","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1038\/s12276-024-01286-z","volume":"56","author":"Y J Kang","year":"2024","unstructured":"Kang, Y. J., Song, W., Lee, S. J., Choi, S. A., Chae, S., Yoon, B. R., Kim, H. Y., Lee, J. H., Kim, C., Cho, J.-Y., Kim, H. J., & Lee, W.-W. (2024). Inhibition of BCAT1-mediated cytosolic leucine metabolism regulates Th17 responses via the mTORC1-HIF1\u03b1 pathway. Experimental & Molecular Medicine, 56(8), 1776\u20131790. https:\/\/doi.org\/10.1038\/s12276-024-01286-z","journal-title":"Experimental & Molecular Medicine"},{"issue":"12","key":"10079_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/jcm7120513","volume":"7","author":"J L Flores-Guerrero","year":"2018","unstructured":"Flores-Guerrero, J. L., Ost\u00e9, M. C. J., Kieneker, L. M., Gruppen, E. G., Wolak-Dinsmore, J., Otvos, J. D., Connelly, M. A., Bakker, S. J. L., & Dullaart, R. P. F. (2018). Plasma branched-chain amino acids and risk of incident type 2 diabetes: Results from the PREVEND prospective cohort study. Journal of Clinical Medicine, 7(12), Article 513.","journal-title":"Journal of Clinical Medicine"},{"key":"10079_CR24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ebiom.2017.12.008","volume":"27","author":"A Mardinoglu","year":"2018","unstructured":"Mardinoglu, A., Gogg, S., Lotta, L. A., Stan\u010d\u00e1kov\u00e1, A., Nerstedt, A., Boren, J., Bl\u00fcher, M., Ferrannini, E., Langenberg, C., Wareham, N. J., & others.(2018). Elevated plasma levels of 3-hydroxyisobutyric acid are associated with incident type 2 diabetes. EBioMedicine, 27, 151\u2013155.","journal-title":"EBioMedicine"},{"issue":"5","key":"10079_CR25","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1007\/s00125-015-3517-8","volume":"58","author":"T Tillin","year":"2015","unstructured":"Tillin, T., Hughes, A. D., Wang, Q., W\u00fcrtz, P., Ala-Korpela, M., Sattar, N., Forouhi, N. G., Godsland, I. F., Eastwood, S. V, McKeigue, P. M., & others. (2015). Diabetes risk and amino acid profiles: Cross-sectional and prospective analyses of ethnicity, amino acids and diabetes in a South Asian and European cohort from the SABRE (Southall and Brent REvisited) study. Diabetologia, 58(5), 968\u2013979.","journal-title":"Diabetologia"},{"issue":"5","key":"10079_CR26","doi-asserted-by":"publisher","first-page":"833","DOI":"10.2337\/dc15-2251","volume":"39","author":"M Guasch-Ferr\u00e9","year":"2016","unstructured":"Guasch-Ferr\u00e9, M., Hruby, A., Toledo, E., Clish, C. B., Mart\\\u2019\\inez-Gonz\u00e1lez, M. A., Salas-Salvad\u00f3, J., & Hu, F. B. (2016). Metabolomics in prediabetes and diabetes: A systematic review and meta-analysis. Diabetes Care, 39(5), 833\u2013846.","journal-title":"Diabetes Care"},{"issue":"10","key":"10079_CR27","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.2337\/db24-1162","volume":"74","author":"RY Jia","year":"2025","unstructured":"Jia, R. Y., Chen, J.-H., Z S., Lam, B. Y. H., Kentistou, K. A., Zhao, Y., Gardner, E. J., Perry, J. R. B., O\u2019Rahilly, S., Day, F. R., & others. (2025). Bidirectional Mendelian randomization indicates causal relationships between Circulating Branched-Chain amino acids and metabolic health. Diabetes, 74(10), 1863\u20131872.","journal-title":"Diabetes"},{"issue":"11","key":"10079_CR28","doi-asserted-by":"publisher","first-page":"e1002179","DOI":"10.1371\/journal.pmed.1002179","volume":"13","author":"LA Lotta","year":"2016","unstructured":"Lotta, L. A., Scott, R. A., Sharp, S. J., Burgess, S., Luan, J., Tillin, T., Schmidt, A. F., Imamura, F., Stewart, I. D., Perry, J. R. B., & others. (2016). Genetic predisposition to an impaired metabolism of the branched-chain amino acids and risk of type 2 diabetes: A Mendelian randomisation analysis. PLoS Medicine, 13(11), e1002179.","journal-title":"PLoS Medicine"},{"issue":"12","key":"10079_CR29","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.2337\/dc17-1642","volume":"40","author":"Q Wang","year":"2017","unstructured":"Wang, Q., Holmes, M. V., Davey Smith, G., & Ala-Korpela, M. (2017). Genetic support for a causal role of insulin resistance on Circulating branched-chain amino acids and inflammation. Diabetes Care, 40(12), 1779\u20131786.","journal-title":"Diabetes Care"},{"issue":"5","key":"10079_CR30","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s00125-017-4222-6","volume":"60","author":"Y Mahendran","year":"2017","unstructured":"Mahendran, Y., Jonsson, A., Have, C. T., Allin, K. H., Witte, D. R., J\u00f8rgensen, M. E., Grarup, N., Pedersen, O., Kilpel\u00e4inen, T. O., & Hansen, T. (2017). Genetic evidence of a causal effect of insulin resistance on branched-chain amino acid levels. Diabetologia, 60(5), 873\u2013878.","journal-title":"Diabetologia"},{"issue":"7","key":"10079_CR31","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.molmet.2016.04.006","volume":"5","author":"PJ White","year":"2016","unstructured":"White, P. J., Lapworth, A. L., An, J., Wang, L., McGarrah, R. W., Stevens, R. D., Ilkayeva, O., George, T., Muehlbauer, M. J., Bain, J. R., Trimmer, J. K., Brosnan, M. J., Rolph, T. P., & Newgard, C. B. (2016). Branched-chain Amino Acid Restriction in Zucker-fatty Rats Improves Muscle Insulin Sensitivity by Enhancing Efficiency of Fatty Acid Oxidation and acyl-glycine Export. Molecular Metabolism, 5(7), 538\u2013551. https:\/\/doi.org\/10.1016\/j.molmet.2016.04.006","journal-title":"Molecular Metabolism"},{"issue":"46","key":"10079_CR32","doi-asserted-by":"publisher","first-page":"15597","DOI":"10.1074\/jbc.RA120.013121","volume":"295","author":"D Biswas","year":"2020","unstructured":"Biswas, D., Dao, K. T., Mercer, A., Cowie, A. M., Duffley, L., El Hiani, Y., Kienesberger, P. C., & Pulinilkunnil, T. (2020). Branched-chain ketoacid overload inhibits insulin action in the muscle. Journal of Biological Chemistry, 295(46), 15597\u201315621.","journal-title":"Journal of Biological Chemistry"},{"issue":"6","key":"10079_CR33","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.cmet.2006.05.003","volume":"3","author":"SH Um","year":"2006","unstructured":"Um, S. H., D\u2019Alessio, D., & Thomas, G. (2006). Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. Cell Metabolism, 3(6), 393\u2013402.","journal-title":"Cell Metabolism"},{"issue":"1","key":"10079_CR34","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1146\/annurev.nutr.25.050304.092545","volume":"27","author":"F Tremblay","year":"2007","unstructured":"Tremblay, F., Lavigne, C., Jacques, H., & Marette, A. (2007). Role of dietary proteins and amino acids in the pathogenesis of insulin resistance. Annual Review of Nutrition, 27(1), 293\u2013310.","journal-title":"Annual Review of Nutrition"},{"issue":"12","key":"10079_CR35","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nrendo.2014.171","volume":"10","author":"CJ Lynch","year":"2014","unstructured":"Lynch, C. J., & Adams, S. H. (2014). Branched-chain amino acids in metabolic signalling and insulin resistance. Nature Reviews. Endocrinology, 10(12), 723\u2013736. https:\/\/doi.org\/10.1038\/nrendo.2014.171","journal-title":"Nature Reviews. Endocrinology"},{"issue":"18","key":"10079_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12186053","volume":"12","author":"DM Tanase","year":"2023","unstructured":"Tanase, D. M., Gosav, E. M., Botoc, T., Floria, M., Tarniceriu, C. C., Maranduca, M. A., Haisan, A., Cucu, A. I., Rezus, C., & Costea, C. F. (2023). Depiction of branched-chain amino acids (BCAAs) in diabetes with a focus on diabetic microvascular complications. Journal of Clinical Medicine, 12(18), Article 6053. https:\/\/doi.org\/10.3390\/jcm12186053","journal-title":"Journal of Clinical Medicine"},{"issue":"1","key":"10079_CR37","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12933-025-02725-5","volume":"24","author":"J Asakura","year":"2025","unstructured":"Asakura, J., Nagao, M., Shinohara, M., Hosooka, T., Kuwahara, N., Nishimori, M., Tanaka, H., Satomi-Kobayashi, S., Matsui, S., Sasaki, T., & others. (2025). Impaired cardiac branched-chain amino acid metabolism in a novel model of diabetic cardiomyopathy. Cardiovascular Diabetology, 24(1), 167.","journal-title":"Cardiovascular Diabetology"},{"key":"10079_CR38","first-page":"62","volume":"106","author":"PS Azevedo","year":"2016","unstructured":"Azevedo, P. S., Polegato, B. F., Minicucci, M. F., Paiva, S. A. R., & Zornoff, L. A. M. (2016). Cardiac remodeling: Concepts, clinical impact, pathophysiological mechanisms and pharmacologic treatment. Arquivos Brasileiros de Cardiologia, 106, 62\u201369.","journal-title":"Arquivos Brasileiros de Cardiologia"},{"key":"10079_CR39","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.123.031617","author":"KS Fine","year":"2024","unstructured":"Fine, K. S., Wilkins, J. T., & Sawicki, K. T. (2024). Circulating branched chain amino acids and cardiometabolic disease. Journal of the American Heart Association. https:\/\/doi.org\/10.1161\/jaha.123.031617","journal-title":"Journal of the American Heart Association"},{"issue":"5","key":"10079_CR40","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1161\/HYPERTENSIONAHA.118.10919","volume":"72","author":"ZY Zhang","year":"2018","unstructured":"Zhang, Z. Y., Monleon, D., Verhamme, P., & Staessen, J. A. (2018). Branched-chain amino acids as critical switches in health and disease. Hypertension, 72(5), 1012\u20131022.","journal-title":"Hypertension"},{"key":"10079_CR41","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.lfs.2015.06.021","volume":"137","author":"Y Tanada","year":"2015","unstructured":"Tanada, Y., Shioi, T., Kato, T., Kawamoto, A., Okuda, J., & Kimura, T. (2015). Branched-chain amino acids ameliorate heart failure with cardiac cachexia in rats. Life Sciences, 137, 20\u201327.","journal-title":"Life Sciences"},{"issue":"4","key":"10079_CR42","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.cmet.2010.08.016","volume":"12","author":"G D\u2019Antona","year":"2010","unstructured":"D\u2019Antona, G., Ragni, M., Cardile, A., Tedesco, L., Dossena, M., Bruttini, F., Caliaro, F., Corsetti, G., Bottinelli, R., Carruba, M. O., Valerio, A., & Nisoli, E. (2010). Branched-Chain amino acid supplementation promotes survival and supports cardiac and skeletal muscle mitochondrial biogenesis in Middle-Aged mice. Cell Metab, 12(4), 362\u2013372. https:\/\/doi.org\/10.1016\/j.cmet.2010.08.016","journal-title":"Cell Metab"},{"issue":"7","key":"10079_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23074022","volume":"23","author":"A Dimou","year":"2022","unstructured":"Dimou, A., Tsimihodimos, V., & Bairaktari, E. (2022). The critical role of the Branched Chain Amino Acids (BCAAs) catabolism-regulating enzymes, Branched-Chain Aminotransferase (BCAT) and Branched-Chain \u03b1-Keto Acid Dehydrogenase (BCKD), in human pathophysiology. International Journal of Molecular Sciences, 23(7), Article 4022. https:\/\/doi.org\/10.3390\/ijms23074022","journal-title":"International Journal of Molecular Sciences"},{"issue":"6","key":"10079_CR44","doi-asserted-by":"publisher","first-page":"1557S","DOI":"10.1093\/jn\/135.6.1557s","volume":"135","author":"SM Hutson","year":"2005","unstructured":"Hutson, S. M., Sweatt, A. J., & LaNoue, K. F. (2005). Branched-chain amino acid metabolism: Implications for establishing safe intakes. Journal of Nutrition, 135(6), 1557S-1564S. https:\/\/doi.org\/10.1093\/jn\/135.6.1557s","journal-title":"Journal of Nutrition"},{"key":"10079_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-024-01263-6","author":"BH Choi","year":"2024","unstructured":"Choi, B. H., Hyun, S., & Koo, S. H. (2024). The role of BCAA metabolism in metabolic health and disease. Experimental & Molecular Medicine. https:\/\/doi.org\/10.1038\/s12276-024-01263-6","journal-title":"Experimental & Molecular Medicine"},{"key":"10079_CR46","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-031-77282-5_32","author":"AC Silva","year":"2025","unstructured":"Silva, A. C., Campos, F., Furtado, G. E., Ferreira, B. P., Rocha, S., & Teixeira, A. M. (2025). Frailty to sustainable vitality: An overview of BCAA and exercise for the well-being of older adults. Sustainability in Aging: Challenges and Opportunities for an Integrated Society. https:\/\/doi.org\/10.1007\/978-3-031-77282-5_32","journal-title":"Sustainability in Aging: Challenges and Opportunities for an Integrated Society"},{"issue":"7","key":"10079_CR47","doi-asserted-by":"publisher","DOI":"10.1111\/apha.70067","volume":"241","author":"M Colardo","year":"2025","unstructured":"Colardo, M., Martella, N., Varone, M., Pensabene, D., Caretti, G., Bianchini, G., Aramini, A., & Segatto, M. (2025). Branched-chain amino acids and di-alanine supplementation attenuates muscle atrophy in a murine model of cancer cachexia. Acta Physiologica, 241(7), Article e70067.","journal-title":"Acta Physiologica"},{"issue":"10","key":"10079_CR48","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.3390\/nu9101047","volume":"9","author":"A Four\u00e9","year":"2017","unstructured":"Four\u00e9, A., & Bendahan, D. (2017). Is branched-chain amino acids supplementation an efficient nutritional strategy to alleviate skeletal muscle damage? A systematic review. Nutrients, 9(10), 1047. https:\/\/doi.org\/10.3390\/nu9101047","journal-title":"Nutrients"},{"issue":"4","key":"10079_CR49","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.037637","volume":"14","author":"DC Nguyen","year":"2025","unstructured":"Nguyen, D. C., Wells, C. K., Taylor, M. S., Martinez-Ondaro, Y., Singhal, R., Brittian, K. R., Brainard, R. E., Moore, J. B., & Hill, B. G. (2025). Dietary branched-chain amino acids modify postinfarct cardiac remodeling and function in the murine heart. Journal of the American Heart Association, 14(4), Article e037637.","journal-title":"Journal of the American Heart Association"},{"key":"10079_CR50","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3390\/nu8070405","volume":"8","author":"MS Yoon","year":"2016","unstructured":"Yoon, M. S. (2016). The emerging role of branched-chain amino acids in insulin resistance and metabolism. Nutrients, 8, 405. https:\/\/doi.org\/10.3390\/nu8070405","journal-title":"Nutrients"},{"key":"10079_CR51","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.biochi.2021.02.008","volume":"184","author":"YF Liang","year":"2021","unstructured":"Liang, Y.-F., Long, Z.-X., Zhang, Y.-J., Luo, C.-Y., Yan, L.-T., Gao, W.-Y., & Li, H. (2021). The chemical mechanisms of the enzymes in the branched-chain amino acids biosynthetic pathway and their applications. Biochimie, 184, 72\u201387.","journal-title":"Biochimie"},{"issue":"4","key":"10079_CR52","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1042\/BCJ20200686","volume":"478","author":"MC Blair","year":"2021","unstructured":"Blair, M. C., Neinast, M. D., & Arany, Z. (2021). Whole-body metabolic fate of branched-chain amino acids. Biochemical Journal, 478(4), 765\u2013776.","journal-title":"Biochemical Journal"},{"issue":"1","key":"10079_CR53","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11897-023-00589-y","volume":"20","author":"SM Ng","year":"2023","unstructured":"Ng, S. M., Neubauer, S., & Rider, O. J. (2023). Myocardial metabolism in heart failure. Current Heart Failure Reports, 20(1), 63\u201375.","journal-title":"Current Heart Failure Reports"},{"issue":"4","key":"10079_CR54","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.15608","volume":"11","author":"T Ogawa","year":"2023","unstructured":"Ogawa, T., Kouzu, H., Osanami, A., Tatekoshi, Y., Sato, T., Kuno, A., Fujita, Y., Ino, S., Shimizu, M., Toda, Y., & others. (2023). Downregulation of extramitochondrial BCKDH and its uncoupling from AMP deaminase in type 2 diabetic OLETF rat hearts. Physiological Reports, 11(4), Article e15608.","journal-title":"Physiological Reports"},{"key":"10079_CR55","doi-asserted-by":"publisher","first-page":"ehab724","DOI":"10.1093\/eurheartj\/ehab724.3228","volume":"42","author":"T Ogawa","year":"2021","unstructured":"Ogawa, T., Kouzu, H., Osanami, A., Tatekoshi, Y., Oshima, H., Mizuno, M., Kuno, A., Fujita, Y., Ino, S., Shimizu, M., & others. (2021). Intracellular localization of AMP deaminase and its novel role in BCAA and lipid metabolism in diabetic cardiomyopathy. European Heart Journal, 42, ehab724-3228.","journal-title":"European Heart Journal"},{"issue":"1","key":"10079_CR56","doi-asserted-by":"publisher","first-page":"13850","DOI":"10.1038\/s41598-017-14120-6","volume":"7","author":"MI Hern\u00e1ndez-Alvarez","year":"2017","unstructured":"Hern\u00e1ndez-Alvarez, M. I., D\u00edaz-Ramos, A., Berdasco, M., Cobb, J., Planet, E., Cooper, D., Pazderska, A., Wanic, K., O\u2019Hanlon, D., Gomez, A., & others. (2017). Early-onset and classical forms of type 2 diabetes show impaired expression of genes involved in muscle branched-chain amino acids metabolism. Scientific Reports, 7(1), 13850.","journal-title":"Scientific Reports"},{"issue":"2","key":"10079_CR57","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cmet.2018.10.013","volume":"29","author":"MD Neinast","year":"2019","unstructured":"Neinast, M. D., Jang, C., Hui, S., Murashige, D. S., Chu, Q., Morscher, R. J., Li, X., Zhan, L., White, E., Anthony, T. G., & others. (2019). Quantitative analysis of the whole-body metabolic fate of branched-chain amino acids. Cell Metab, 29(2), 417\u2013429.","journal-title":"Cell Metab"},{"issue":"1","key":"10079_CR58","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.2047-6310.2012.00087.x","volume":"8","author":"SE McCormack","year":"2013","unstructured":"McCormack, S. E., Shaham, O., McCarthy, M. A., Deik, A. A., Wang, T. J., Gerszten, R. E., Clish, C. B., Mootha, V. K., Grinspoon, S. K., & Fleischman, A. (2013). Circulating branched-chain amino acid concentrations are associated with obesity and future insulin resistance in children and adolescents. Pediatric Obesity, 8(1), 52\u201361.","journal-title":"Pediatric Obesity"},{"issue":"8","key":"10079_CR59","doi-asserted-by":"publisher","first-page":"8711","DOI":"10.1096\/fj.201802842RR","volume":"33","author":"D Biswas","year":"2019","unstructured":"Biswas, D., Duffley, L., & Pulinilkunnil, T. (2019). Role of branched-chain amino acid\u2013catabolizing enzymes in intertissue signaling, metabolic remodeling, and energy homeostasis. The Faseb Journal, 33(8), 8711\u20138731.","journal-title":"The Faseb Journal"},{"key":"10079_CR60","doi-asserted-by":"publisher","first-page":"702826","DOI":"10.3389\/fphys.2021.702826","volume":"12","author":"G Mann","year":"2021","unstructured":"Mann, G., Mora, S., Madu, G., & Adegoke, O. A. J. (2021). Branched-chain amino acids: Catabolism in skeletal muscle and implications for muscle and whole-body metabolism. Frontiers in Physiology, 12, 702826.","journal-title":"Frontiers in Physiology"},{"issue":"7","key":"10079_CR61","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1038\/s41401-023-01076-9","volume":"44","author":"J Yu","year":"2023","unstructured":"Yu, J., Cao, N., Rau, C. D., Lee, R.-P., Yang, J., Flach, R. J. R., Petersen, L., Zhu, C., Pak, Y.-L., Miller, R. A., & others. (2023). Cell-autonomous effect of cardiomyocyte branched-chain amino acid catabolism in heart failure in mice. Acta Pharmacologica Sinica, 44(7), 1380\u20131390.","journal-title":"Acta Pharmacologica Sinica"},{"issue":"2","key":"10079_CR62","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s10557-022-07320-4","volume":"37","author":"QG Karwi","year":"2023","unstructured":"Karwi, Q. G., & Lopaschuk, G. D. (2023). Branched-chain amino acid metabolism in the failing heart. Cardiovascular Drugs and Therapy, 37(2), 413\u2013420.","journal-title":"Cardiovascular Drugs and Therapy"},{"issue":"4","key":"10079_CR63","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nm.4057","volume":"22","author":"C Jang","year":"2016","unstructured":"Jang, C., Oh, S. F., Wada, S., Rowe, G. C., Liu, L., Chan, M. C., Rhee, J., Hoshino, A., Kim, B., Ibrahim, A., Baca, L. G., Kim, E., Ghosh, C. C., Parikh, S. M., Jiang, A., Chu, Q., Forman, D. E., Lecker, S. H., Krishnaiah, S., \u2026 Arany, Z. (2016). A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance. Nature Medicine, 22(4), 421\u2013426. https:\/\/doi.org\/10.1038\/nm.4057","journal-title":"Nature Medicine"},{"issue":"2","key":"10079_CR64","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.cmet.2016.11.005","volume":"25","author":"T Li","year":"2017","unstructured":"Li, T., Zhang, Z., Kolwicz, S. C., Abell, L., Roe, N. D., Kim, M., Zhou, B., Cao, Y., Ritterhoff, J., Gu, H., Raftery, D., Sun, H., & Tian, R. (2017). Defective branched-chain amino acid catabolism disrupts glucose metabolism and sensitizes the heart to ischemia-reperfusion injury. Cell Metabolism, 25(2), 374\u2013385. https:\/\/doi.org\/10.1016\/j.cmet.2016.11.005","journal-title":"Cell Metabolism"},{"issue":"4","key":"10079_CR65","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1113\/jp275075","volume":"596","author":"NE Cummings","year":"2017","unstructured":"Cummings, N. E., Williams, E. M., Kasza, I., Konon, E. N., Schaid, M. D., Schmidt, B. A., Poudel, C., Sherman, D. S., Yu, D., Arriola Apelo, S. I., Cottrell, S. E., Geiger, G., Barnes, M. E., Wisinski, J. A., Fenske, R. J., Matkowskyj, K. A., Kimple, M. E., Alexander, C. M., Merrins, M. J., & Lamming, D. W. (2017). Restoration of metabolic health by decreased consumption of branched-chain amino acids. The Journal of Physiology, 596(4), 623\u2013645. https:\/\/doi.org\/10.1113\/jp275075","journal-title":"The Journal of Physiology"},{"issue":"1","key":"10079_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/nu13010095","volume":"13","author":"I Ramzan","year":"2020","unstructured":"Ramzan, I., Taylor, M., Phillips, B., Wilkinson, D., Smith, K., Hession, K., Idris, I., & Atherton, P. (2020). A novel dietary intervention reduces circulatory branched-chain amino acids by 50\\%: A pilot study of relevance for obesity and diabetes. Nutrients, 13(1), Article 95.","journal-title":"Nutrients"},{"issue":"2","key":"10079_CR67","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.celrep.2016.05.092","volume":"16","author":"L Fontana","year":"2016","unstructured":"Fontana, L., Cummings, N. E., Arriola Apelo, S. I., Neuman, J. C., Kasza, I., Schmidt, B. A., Cava, E., Spelta, F., Tosti, V., Syed, F. A., Baar, E. L., Veronese, N., Cottrell, S. E., Fenske, R. J., Bertozzi, B., Brar, H. K., Pietka, T., Bullock, A. D., Figenshau, R. S., \u2026 Lamming, D. W. (2016). Decreased consumption of branched-chain amino acids improves metabolic health. Cell Reports, 16(2), 520\u2013530. https:\/\/doi.org\/10.1016\/j.celrep.2016.05.092","journal-title":"Cell Reports"},{"issue":"6","key":"10079_CR68","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13626","volume":"21","author":"ME Trautman","year":"2022","unstructured":"Trautman, M. E., Richardson, N. E., & Lamming, D. W. (2022). Protein restriction and branched-chain amino acid restriction promote geroprotective shifts in metabolism. Aging Cell, 21(6), Article e13626.","journal-title":"Aging Cell"},{"issue":"4","key":"10079_CR69","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1113\/JP275075","volume":"596","author":"NE Cummings","year":"2018","unstructured":"Cummings, N. E., Williams, E. M., Kasza, I., Konon, E. N., Schaid, M. D., Schmidt, B. A., Poudel, C., Sherman, D. S., Yu, D., Arriola Apelo, S. I., & others. (2018). Restoration of metabolic health by decreased consumption of branched-chain amino acids. The Journal of Physiology, 596(4), 623\u2013645.","journal-title":"The Journal of Physiology"},{"issue":"7","key":"10079_CR70","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.1074\/jbc.M113.521062","volume":"289","author":"A Das","year":"2014","unstructured":"Das, A., Durrant, D., Koka, S., Salloum, F. N., Xi, L., & Kukreja, R. C. (2014). Mammalian target of Rapamycin (mTOR) inhibition with Rapamycin improves cardiac function in type 2 diabetic mice POTENTIAL ROLE OF ATTENUATED OXIDATIVE STRESS AND ALTERED CONTRACTILE PROTEIN EXPRESSION. The Journal of Biological Chemistry, 289(7), 4145\u20134160. https:\/\/doi.org\/10.1074\/jbc.M113.521062","journal-title":"The Journal of Biological Chemistry"},{"key":"10079_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-023-01061-6","author":"L Zhang","year":"2023","unstructured":"Zhang, L., Zhang, H., Xie, X., Tie, R., Shang, X., Zhao, Q., Xu, J., Jin, L., Zhang, J., & Ye, P. (2023). Empagliflozin ameliorates diabetic cardiomyopathy via regulated branched-chain amino acid metabolism and mTOR\/p-ULK1 signaling pathway-mediated autophagy. Diabetology & Metabolic Syndrome. https:\/\/doi.org\/10.1186\/s13098-023-01061-6","journal-title":"Diabetology & Metabolic Syndrome"},{"issue":"5","key":"10079_CR72","doi-asserted-by":"publisher","first-page":"H1160","DOI":"10.1152\/ajpheart.00114.2016","volume":"311","author":"W Wang","year":"2016","unstructured":"Wang, W., Zhang, F., Xia, Y., Zhao, S., Yan, W., Wang, H., Lu, Y., Li, C., Zhang, L., Lian, K., Gao, E., Cheng, H., & Tao, L. (2016). Defective branched chain amino acid catabolism contributes to cardiac dysfunction and remodeling following myocardial infarction. American Journal of Physiology-Heart and Circulatory Physiology, 311(5), H1160\u2013H1169. https:\/\/doi.org\/10.1152\/ajpheart.00114.2016","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"issue":"11","key":"10079_CR73","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/j.cmet.2022.09.008","volume":"34","author":"D Murashige","year":"2022","unstructured":"Murashige, D., Jung, J. W., Neinast, M. D., Levin, M. G., Chu, Q., Lambert, J. P., Garbincius, J. F., Kim, B., Hoshino, A., Marti-Pamies, I., & others. (2022). Extra-cardiac BCAA catabolism lowers blood pressure and protects from heart failure. Cell Metabolism, 34(11), 1749\u20131764.","journal-title":"Cell Metabolism"},{"issue":"1","key":"10079_CR74","doi-asserted-by":"publisher","first-page":"3508","DOI":"10.1038\/s41467-022-31249-9","volume":"13","author":"F Vanweert","year":"2022","unstructured":"Vanweert, F., Neinast, M., Tapia, E. E., van de Weijer, T., Hoeks, J., Schrauwen-Hinderling, V. B., Blair, M. C., Bornstein, M. R., Hesselink, M. K. C., Schrauwen, P., & others. (2022). A randomized placebo-controlled clinical trial for pharmacological activation of BCAA catabolism in patients with type 2 diabetes. Nature Communications, 13(1), 3508.","journal-title":"Nature Communications"},{"issue":"6","key":"10079_CR75","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1172\/jci38151","volume":"119","author":"G Lu","year":"2009","unstructured":"Lu, G., Sun, H., She, P., Youn, J.-Y., Warburton, S., Ping, P., Vondriska, T. M., Cai, H., Lynch, C. J., & Wang, Y. (2009). Protein phosphatase 2Cm is a critical regulator of branched-chain amino acid catabolism in mice and cultured cells. Journal of Clinical Investigation, 119(6), 1678\u20131687. https:\/\/doi.org\/10.1172\/jci38151","journal-title":"Journal of Clinical Investigation"},{"issue":"6","key":"10079_CR76","doi-asserted-by":"publisher","first-page":"e65763","DOI":"10.1371\/journal.pone.0065763","volume":"8","author":"AC Adams","year":"2013","unstructured":"Adams, A. C., Halstead, C. A., Hansen, B. C., Irizarry, A. R., Martin, J. A., Myers, S. R., Reynolds, V. L., Smith, H. W., Wroblewski, V. J., & Kharitonenkov, A. (2013). LY2405319, an engineered FGF21 variant, improves the metabolic status of diabetic monkeys. PLoS One, 8(6), e65763.","journal-title":"PLoS One"},{"issue":"3","key":"10079_CR77","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.cmet.2013.08.005","volume":"18","author":"G Gaich","year":"2013","unstructured":"Gaich, G., Chien, J. Y., Fu, H., Glass, L. C., Deeg, M. A., Holland, W. L., Kharitonenkov, A., Bumol, T., Schilske, H. K., & Moller, D. E. (2013). The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes. Cell Metabolism, 18(3), 333\u2013340. https:\/\/doi.org\/10.1016\/j.cmet.2013.08.005","journal-title":"Cell Metabolism"},{"issue":"3","key":"10079_CR78","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.cmet.2016.02.001","volume":"23","author":"S Talukdar","year":"2016","unstructured":"Talukdar, S., Zhou, Y., Li, D., Rossulek, M., Dong, J., Somayaji, V., Weng, Y., Clark, R., Lanba, A., Owen, B. M., Brenner, M. B., Trimmer, J. K., Gropp, K. E., Chabot, J. R., Erion, D. M., Rolph, T. P., Goodwin, B., & Calle, R. A. (2016). A long-acting FGF21 molecule, PF-05231023, decreases body weight and improves lipid profile in non-human primates and type 2 diabetic subjects. Cell Metabolism, 23(3), 427\u2013440. https:\/\/doi.org\/10.1016\/j.cmet.2016.02.001","journal-title":"Cell Metabolism"},{"issue":"35","key":"10079_CR79","doi-asserted-by":"publisher","first-page":"eaaz9890","DOI":"10.1126\/sciadv.aaz9890","volume":"6","author":"CA Gilroy","year":"2020","unstructured":"Gilroy, C. A., Capozzi, M. E., Varanko, A. K., Tong, J., D\u2019alessio, D. A., Campbell, J. E., & Chilkoti, A. (2020). Sustained release of a GLP-1 and FGF21 dual agonist from an injectable depot protects mice from obesity and hyperglycemia. Science Advances, 6(35), eaaz9890.","journal-title":"Science Advances"},{"issue":"24","key":"10079_CR80","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1161\/01.CIR.0000039346.31538.2C","volume":"106","author":"T Shiomi","year":"2002","unstructured":"Shiomi, T., Tsutsui, H., Hayashidani, S., Suematsu, N., Ikeuchi, M., Wen, J., Ishibashi, M., Kubota, T., Egashira, K., & Takeshita, A. (2002). Pioglitazone, a peroxisome proliferator\u2013activated receptor-\u03b3 agonist, attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation, 106(24), 3126\u20133132.","journal-title":"Circulation"},{"key":"10079_CR81","doi-asserted-by":"publisher","first-page":"6121","DOI":"10.12659\/MSM.907401","volume":"23","author":"H Gao","year":"2017","unstructured":"Gao, H., Li, H., Li, W., Shen, X., & Di, B. (2017). Pioglitazone attenuates atherosclerosis in diabetic mice by inhibition of receptor for advanced glycation end-product (RAGE) signaling. Medical Science Monitor\u202f: International Medical Journal of Experimental and Clinical Research, 23, 6121.","journal-title":"Medical Science Monitor : International Medical Journal of Experimental and Clinical Research"},{"issue":"2","key":"10079_CR82","doi-asserted-by":"publisher","first-page":"E163","DOI":"10.1152\/ajpendo.00023.2018","volume":"315","author":"S Kalavalapalli","year":"2018","unstructured":"Kalavalapalli, S., Bril, F., Koelmel, J. P., Abdo, K., Guingab, J., Andrews, P., Li, W.-Y., Jose, D., Yost, R. A., Frye, R. F., & others. (2018). Pioglitazone improves hepatic mitochondrial function in a mouse model of nonalcoholic steatohepatitis. American Journal of Physiology-Endocrinology and Metabolism, 315(2), E163\u2013E173.","journal-title":"American Journal of Physiology-Endocrinology and Metabolism"},{"issue":"1","key":"10079_CR83","volume":"2016","author":"W-Y Wei","year":"2016","unstructured":"Wei, W.-Y., Ma, Z.-G., Xu, S.-C., Zhang, N., & Tang, Q.-Z. (2016). Pioglitazone protected against cardiac hypertrophy via inhibiting AKT\/GSK3\u03b2 and MAPK signaling pathways. PPAR Research, 2016(1), Article 9174190.","journal-title":"PPAR Research"},{"issue":"1","key":"10079_CR84","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-019-0979-x","volume":"19","author":"C-H Liu","year":"2020","unstructured":"Liu, C.-H., Lee, T.-H., Lin, Y.-S., Sung, P.-S., Wei, Y.-C., & Li, Y.-R. (2020). Pioglitazone and PPAR-\u03b3 modulating treatment in hypertensive and type 2 diabetic patients after ischemic stroke: A national cohort study. Cardiovascular Diabetology, 19(1), Article 2.","journal-title":"Cardiovascular Diabetology"},{"issue":"11","key":"10079_CR85","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1007\/s00125-023-05985-6","volume":"66","author":"X Zhao","year":"2023","unstructured":"Zhao, X., Zhang, X., Pei, J., Liu, Y., Niu, W., & Sun, H. (2023). Targeting BCAA metabolism to potentiate metformin\u2019s therapeutic efficacy in the treatment of diabetes in mice. Diabetologia, 66(11), 2139\u20132153. https:\/\/doi.org\/10.1007\/s00125-023-05985-6","journal-title":"Diabetologia"},{"key":"10079_CR86","doi-asserted-by":"publisher","first-page":"102342","DOI":"10.1016\/j.redox.2022.102342","volume":"53","author":"AM de Mara\u00f1\u00f3n","year":"2022","unstructured":"de Mara\u00f1\u00f3n, A. M., D\u00edaz-Pozo, P., Canet, F., D\u00edaz-Morales, N., Abad-Jim\u00e9nez, Z., L\u00f3pez-Dom\u00e8nech, S., Vezza, T., Apostolova, N., Morillas, C., Rocha, M., & V\u00edctor, V. M. (2022). Metformin modulates mitochondrial function and mitophagy in peripheral blood mononuclear cells from type 2 diabetic patients. Redox Biology, 53, 102342. https:\/\/doi.org\/10.1016\/j.redox.2022.102342","journal-title":"Redox Biology"},{"issue":"22","key":"10079_CR87","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1161\/circulationaha.121.056756","volume":"145","author":"RB Goldberg","year":"2022","unstructured":"Goldberg, R. B., Orchard, T. J., Crandall, J. P., Boyko, E. J., Budoff, M., Dabelea, D., Gadde, K. M., Knowler, W. C., Lee, C. G., Nathan, D. M., Watson, K., & Temprosa, M. (2022). Effects of long-term metformin and lifestyle interventions on cardiovascular events in the diabetes prevention program and its outcome study. Circulation, 145(22), 1632\u20131641. https:\/\/doi.org\/10.1161\/circulationaha.121.056756","journal-title":"Circulation"},{"issue":"11","key":"10079_CR88","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1111\/dme.13097","volume":"33","author":"D Preiss","year":"2016","unstructured":"Preiss, D., Rankin, N., Welsh, P., Holman, R. R., Kangas, A. J., Soininen, P., W\u00fcrtz, P., Ala-Korpela, M., & Sattar, N. (2016). Effect of metformin therapy on circulating amino acids in a randomized trial: The CAMERA study. Diabetic Medicine, 33(11), 1569\u20131574.","journal-title":"Diabetic Medicine"},{"issue":"6","key":"10079_CR89","doi-asserted-by":"publisher","first-page":"766","DOI":"10.3390\/metabo13060766","volume":"13","author":"CN Rivera","year":"2023","unstructured":"Rivera, C. N., Smith, C. E., Draper, L. V, Ochoa, G. E., Watne, R. M., Wommack, A. J., & Vaughan, R. A. (2023). The selective LAT1 inhibitor JPH203 enhances mitochondrial metabolism and content in insulin-sensitive and insulin-resistant C2C12 myotubes. Metabolites, 13(6), 766.","journal-title":"Metabolites"},{"issue":"6","key":"10079_CR90","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.cmet.2018.04.015","volume":"27","author":"PJ White","year":"2018","unstructured":"White, P. J., McGarrah, R. W., Grimsrud, P. A., Tso, S.-C., Yang, W.-H., Haldeman, J. M., Grenier-Larouche, T., An, J., Lapworth, A. L., Astapova, I., Hannou, S. A., George, T., Arlotto, M., Olson, L. B., Lai, M., Zhang, G.-F., Ilkayeva, O., Herman, M. A., Wynn, R. M., \u2026 Newgard, C. B. (2018). The BCKDH kinase and phosphatase integrate BCAA and lipid metabolism via regulation of ATP-citrate lyase. Cell Metabolism, 27(6), 1281-1293.e7. https:\/\/doi.org\/10.1016\/j.cmet.2018.04.015","journal-title":"Cell Metabolism"},{"issue":"9","key":"10079_CR91","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.2337\/db18-0927","volume":"68","author":"M Zhou","year":"2019","unstructured":"Zhou, M., Shao, J., Wu, C.-Y., Shu, L., Dong, W., Liu, Y., Chen, M., Wynn, R. M., Wang, J., Wang, J., Gui, W.-J., Qi, X., Lusis, A. J., Li, Z., Wang, W., Ning, G., Yang, X., Chuang, D. T., Wang, Y., & Sun, H. (2019). Targeting BCAA catabolism to treat obesity-associated insulin resistance. Diabetes, 68(9), 1730\u20131746. https:\/\/doi.org\/10.2337\/db18-0927","journal-title":"Diabetes"},{"key":"10079_CR92","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13626","author":"ME Murphy","year":"2022","unstructured":"Murphy, M. E., Richardson, N., & Lamming, D. W. (2022). Protein restriction and branched-chain amino acid restriction promote geroprotective shifts in metabolism. Aging Cell. https:\/\/doi.org\/10.1111\/acel.13626","journal-title":"Aging Cell"},{"key":"10079_CR93","doi-asserted-by":"publisher","first-page":"101198","DOI":"10.1016\/j.arr.2020.101198","volume":"64","author":"DG Le Couteur","year":"2020","unstructured":"Le Couteur, D. G., Solon-Biet, S. M., Cogger, V. C., Ribeiro, R., de Cabo, R., Raubenheimer, D., Cooney, G. J., & Simpson, S. J. (2020). Branched chain amino acids, aging and age-related health. Ageing Research Reviews, 64, 101198. https:\/\/doi.org\/10.1016\/j.arr.2020.101198","journal-title":"Ageing Research Reviews"},{"key":"10079_CR94","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.772573","volume":"8","author":"S Langyan","year":"2022","unstructured":"Langyan, S., Yadava, P., Khan, F. N., Dar, Z. A., Singh, R., & Kumar, A. (2022). Sustaining protein nutrition through plant-based foods. Frontiers in Nutrition, 8, Article 772573.","journal-title":"Frontiers in Nutrition"},{"key":"10079_CR95","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/B978-0-323-91739-1.00019-2","volume-title":"Future Proteins","author":"J Tomi\u0107","year":"2023","unstructured":"Tomi\u0107, J., \u0160krobot, D., & Poji\u0107, M. (2023). Shift to plant-based proteins: Environmental, economic, and social implications. Future Proteins (pp. 411\u2013423). Elsevier."},{"issue":"11","key":"10079_CR96","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.3390\/nu9111271","volume":"9","author":"Y Kim","year":"2017","unstructured":"Kim, Y., Keogh, J., & Clifton, P. (2017). Benefits of nut consumption on insulin resistance and cardiovascular risk factors: Multiple potential mechanisms of actions. Nutrients, 9(11), 1271. https:\/\/doi.org\/10.3390\/nu9111271","journal-title":"Nutrients"},{"issue":"12","key":"10079_CR97","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.numecd.2015.08.006","volume":"25","author":"DJA Jenkins","year":"2015","unstructured":"Jenkins, D. J. A., Jones, P. J., Frohlich, J., Lamarche, B., Ireland, C., Nishi, S. K., Srichaikul, K., Galange, P., Pellini, C., Faulkner, D., de Souza, R. J., Sievenpiper, J. L., Mirrahimi, A., Jayalath, V. H., Augustin, L. S., Bashyam, B., Leiter, L. A., Josse, R., Couture, P., \u2026 Kendall, C. W. C. (2015). The effect of a dietary portfolio compared to a DASH-type diet on blood pressure. Nutrition, Metabolism, and Cardiovascular Diseases\u202f: NMCD, 25(12), 1132\u20131139. https:\/\/doi.org\/10.1016\/j.numecd.2015.08.006","journal-title":"Nutrition, Metabolism, and Cardiovascular Diseases : NMCD"},{"issue":"7","key":"10079_CR98","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.tcm.2018.02.004","volume":"28","author":"A Satija","year":"2018","unstructured":"Satija, A., & Hu, F. B. (2018). Plant-based diets and cardiovascular health. Trends in Cardiovascular Medicine, 28(7), 437\u2013441. https:\/\/doi.org\/10.1016\/j.tcm.2018.02.004","journal-title":"Trends in Cardiovascular Medicine"},{"issue":"11","key":"10079_CR99","doi-asserted-by":"publisher","first-page":"E2661","DOI":"10.3390\/nu11112661","volume":"11","author":"F Mariotti","year":"2019","unstructured":"Mariotti, F., & Gardner, C. D. (2019). Dietary protein and amino acids in vegetarian diets-a review. Nutrients, 11(11), E2661. https:\/\/doi.org\/10.3390\/nu11112661","journal-title":"Nutrients"},{"issue":"11","key":"10079_CR100","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1111\/obr.12439","volume":"17","author":"F Eichelmann","year":"2016","unstructured":"Eichelmann, F., Schwingshackl, L., Fedirko, V., & Aleksandrova, K. (2016). Effect of plant-based diets on obesity-related inflammatory profiles: A systematic review and meta-analysis of intervention trials. Obesity Reviews, 17(11), 1067\u20131079. https:\/\/doi.org\/10.1111\/obr.12439","journal-title":"Obesity Reviews"},{"issue":"15","key":"10079_CR101","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1161\/circulationaha.118.035225","volume":"139","author":"M Guasch-Ferr\u00e9","year":"2019","unstructured":"Guasch-Ferr\u00e9, M., Satija, A., Blondin, S. A., Janiszewski, M., Emlen, E., O\u2019Connor, L. E., Campbell, W. W., Hu, F. B., Willett, W. C., & Stampfer, M. J. (2019). Meta-analysis of randomized controlled trials of red meat consumption in comparison with various comparison diets on cardiovascular risk factors. Circulation, 139(15), 1828\u20131845. https:\/\/doi.org\/10.1161\/circulationaha.118.035225","journal-title":"Circulation"},{"issue":"6","key":"10079_CR102","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","volume":"168","author":"RA Saxton","year":"2017","unstructured":"Saxton, R. A., & Sabatini, D. M. (2017). MTOR signaling in growth, metabolism, and disease. Cell, 168(6), 960\u2013976. https:\/\/doi.org\/10.1016\/j.cell.2017.02.004","journal-title":"Cell"},{"issue":"4","key":"10079_CR103","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1093\/jmcb\/mjq038","volume":"3","author":"X Wang","year":"2010","unstructured":"Wang, X., & Proud, C. G. (2010). MTORC1 signaling: What we still don\u2019t know. Journal of Molecular Cell Biology, 3(4), 206\u2013220. https:\/\/doi.org\/10.1093\/jmcb\/mjq038","journal-title":"Journal of Molecular Cell Biology"},{"issue":"3","key":"10079_CR104","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1161\/circresaha.114.302022","volume":"114","author":"S Sciarretta","year":"2014","unstructured":"Sciarretta, S., Volpe, M., & Sadoshima, J. (2014). Mammalian target of Rapamycin signaling in cardiac physiology and disease. Circulation Research, 114(3), 549\u2013564. https:\/\/doi.org\/10.1161\/circresaha.114.302022","journal-title":"Circulation Research"},{"issue":"3","key":"10079_CR105","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1161\/circresaha.117.311147","volume":"122","author":"S Sciarretta","year":"2018","unstructured":"Sciarretta, S., Forte, M., Frati, G., & Sadoshima, J. (2018). New insights into the role of mTOR signaling in the cardiovascular system. Circulation Research, 122(3), 489\u2013505. https:\/\/doi.org\/10.1161\/circresaha.117.311147","journal-title":"Circulation Research"},{"issue":"4","key":"10079_CR106","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1124\/pr.112.007120","volume":"65","author":"Y Cheng","year":"2013","unstructured":"Cheng, Y., Ren, X., Hait, W. N., & Yang, J. M. (2013). Therapeutic targeting of autophagy in disease: Biology and pharmacology. Pharmacological Reviews, 65(4), 1162\u20131197. https:\/\/doi.org\/10.1124\/pr.112.007120","journal-title":"Pharmacological Reviews"},{"issue":"6","key":"10079_CR107","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1042\/ebc20170027","volume":"61","author":"Y Rabanal-Ruiz","year":"2017","unstructured":"Rabanal-Ruiz, Y., Otten, E. G., & Korolchuk, V. I. (2017). mTORC1 as the main gateway to autophagy. Essays in Biochemistry, 61(6), 565\u2013584. https:\/\/doi.org\/10.1042\/ebc20170027","journal-title":"Essays in Biochemistry"},{"issue":"1","key":"10079_CR108","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1172\/jci73939","volume":"125","author":"YC Kim","year":"2015","unstructured":"Kim, Y. C., & Guan, K.-L. (2015). mTOR: A pharmacologic target for autophagy regulation. Journal of Clinical Investigation, 125(1), 25\u201332. https:\/\/doi.org\/10.1172\/jci73939","journal-title":"Journal of Clinical Investigation"},{"key":"10079_CR109","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1146\/annurev-physiol-020518-114455","volume":"81","author":"M Neinast","year":"2019","unstructured":"Neinast, M., Murashige, D., & Arany, Z. (2019). Branched chain amino acids. Annual Review of Physiology, 81, 139\u2013164. https:\/\/doi.org\/10.1146\/annurev-physiol-020518-114455","journal-title":"Annual Review of Physiology"},{"issue":"R1","key":"10079_CR110","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1093\/hmg\/ddu123","volume":"23","author":"LC Burrage","year":"2014","unstructured":"Burrage, L. C., Nagamani, S. C. S., Campeau, P. M., & Lee, B. H. (2014). Branched-chain amino acid metabolism: From rare Mendelian diseases to more common disorders. Human Molecular Genetics, 23(R1), R1\u2013R8. https:\/\/doi.org\/10.1093\/hmg\/ddu123","journal-title":"Human Molecular Genetics"},{"issue":"30","key":"10079_CR111","doi-asserted-by":"publisher","first-page":"20583","DOI":"10.1074\/jbc.M114.569251","volume":"289","author":"S-C Tso","year":"2014","unstructured":"Tso, S.-C., Gui, W.-J., Wu, C.-Y., Chuang, J. L., Qi, X., Skvorak, K. J., Dorko, K., Wallace, A. L., Morlock, L. K., Lee, B. H., & others. (2014). Benzothiophene carboxylate derivatives as novel allosteric inhibitors of branched-chain \u03b1-ketoacid dehydrogenase kinase. Journal of Biological Chemistry, 289(30), 20583\u201320593.","journal-title":"Journal of Biological Chemistry"},{"issue":"3","key":"10079_CR112","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1113\/EP089223","volume":"106","author":"H Crossland","year":"2021","unstructured":"Crossland, H., Smith, K., Idris, I., Phillips, B. E., Atherton, P. J., & Wilkinson, D. J. (2021). Phenylbutyrate, a branched-chain amino acid keto dehydrogenase activator, promotes branched-chain amino acid metabolism and induces muscle catabolism in C2C12 cells. Experimental Physiology, 106(3), 585\u2013592.","journal-title":"Experimental Physiology"},{"issue":"6","key":"10079_CR113","doi-asserted-by":"publisher","first-page":"1527S","DOI":"10.1093\/jn\/135.6.1527s","volume":"135","author":"RA Harris","year":"2005","unstructured":"Harris, R. A., Joshi, M., Jeoung, N. H., & Obayashi, M. (2005). Overview of the molecular and biochemical basis of branched-chain amino acid catabolism. Journal of Nutrition, 135(6), 1527S-1530S. https:\/\/doi.org\/10.1093\/jn\/135.6.1527s","journal-title":"Journal of Nutrition"},{"issue":"3","key":"10079_CR114","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00246-010-9856-9","volume":"32","author":"H Sun","year":"2011","unstructured":"Sun, H., Lu, G., Ren, S., Chen, J., & Wang, Y. (2011). Catabolism of branched-chain amino acids in heart failure: Insights from genetic models. Pediatric Cardiology, 32(3), 305\u2013310. https:\/\/doi.org\/10.1007\/s00246-010-9856-9","journal-title":"Pediatric Cardiology"},{"issue":"1","key":"10079_CR115","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrd.2015.9","volume":"15","author":"C Degirolamo","year":"2015","unstructured":"Degirolamo, C., Sabb\u00e0, C., & Moschetta, A. (2015). Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23. Nature Reviews. Drug Discovery, 15(1), 51\u201369. https:\/\/doi.org\/10.1038\/nrd.2015.9","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"1","key":"10079_CR116","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1146\/annurev-nutr-071816-064800","volume":"38","author":"LD BonDurant","year":"2018","unstructured":"BonDurant, L. D., & Potthoff, M. J. (2018). Fibroblast growth factor 21: A versatile regulator of metabolic homeostasis. Annual Review of Nutrition, 38(1), 173\u2013196. https:\/\/doi.org\/10.1146\/annurev-nutr-071816-064800","journal-title":"Annual Review of Nutrition"},{"key":"10079_CR117","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2015.00133","author":"A Planavila","year":"2015","unstructured":"Planavila, A., Redondo-Angulo, I., & Villarroya, F. (2015). FGF21 and cardiac physiopathology. Frontiers in Endocrinology. https:\/\/doi.org\/10.3389\/fendo.2015.00133","journal-title":"Frontiers in Endocrinology"},{"key":"10079_CR118","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2014.00107","author":"N Itoh","year":"2014","unstructured":"Itoh, N. (2014). FGF21 as a Hepatokine, adipokine, and myokine in metabolism and diseases. Frontiers in Endocrinology. https:\/\/doi.org\/10.3389\/fendo.2014.00107","journal-title":"Frontiers in Endocrinology"},{"key":"10079_CR119","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2015.00168","author":"J Zhang","year":"2015","unstructured":"Zhang, J., & Li, Y. (2015). Fibroblast growth factor 21 analogs for treating metabolic disorders. Frontiers in Endocrinology. https:\/\/doi.org\/10.3389\/fendo.2015.00168","journal-title":"Frontiers in Endocrinology"},{"issue":"1","key":"10079_CR120","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11684-013-0244-8","volume":"7","author":"H Li","year":"2013","unstructured":"Li, H., Zhang, J., & Jia, W. (2013). Fibroblast growth factor 21: A novel metabolic regulator from pharmacology to physiology. Frontiers in Medicine, 7(1), 25\u201330. https:\/\/doi.org\/10.1007\/s11684-013-0244-8","journal-title":"Frontiers in Medicine"},{"issue":"1","key":"10079_CR121","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.mce.2011.05.003","volume":"342","author":"Y Zhang","year":"2011","unstructured":"Zhang, Y., Lei, T., Huang, J. F., Wang, S. B., Zhou, L. L., Yang, Z. Q., & Chen, X. D. (2011). The link between fibroblast growth factor 21 and sterol regulatory element binding protein 1c during lipogenesis in hepatocytes. Molecular and Cellular Endocrinology, 342(1), 41\u201347. https:\/\/doi.org\/10.1016\/j.mce.2011.05.003","journal-title":"Molecular and Cellular Endocrinology"},{"issue":"3","key":"10079_CR122","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1101\/gad.177857.111","volume":"26","author":"M Fisher","year":"2012","unstructured":"Fisher, ffolliott M., Kleiner, S., Douris, N., Fox, E. C., Mepani, R. J., Verdeguer, F., Wu, J., Kharitonenkov, A., Flier, J. S., Maratos-Flier, E., & Spiegelman, B. M. (2012). FGF21 regulates PGC-1\u03b1 and Browning of white adipose tissues in adaptive thermogenesis. Genes & Development, 26(3), 271\u2013281. https:\/\/doi.org\/10.1101\/gad.177857.111","journal-title":"Genes & Development"},{"issue":"5","key":"10079_CR123","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.cmet.2013.04.005","volume":"17","author":"Z Lin","year":"2013","unstructured":"Lin, Z., Tian, H., Lam, K. S. L., Lin, S., Konishi, M., Itoh, N., Wang, Y., Bornstein, S. R., Xu, A., & Li, X. (2013). Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice. Cell Metabolism, 17(5), 779\u2013789. https:\/\/doi.org\/10.1016\/j.cmet.2013.04.005","journal-title":"Cell Metabolism"},{"key":"10079_CR124","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101261","volume":"52","author":"PJ White","year":"2021","unstructured":"White, P. J., McGarrah, R. W., Herman, M. A., Bain, J. R., Shah, S. H., & Newgard, C. B. (2021). Insulin action, type 2 diabetes, and branched-chain amino acids: A two-way street. Molecular Metabolism, Article 101261. https:\/\/doi.org\/10.1016\/j.molmet.2021.101261","journal-title":"Molecular Metabolism"},{"issue":"21","key":"10079_CR125","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1161\/circulationaha.115.020226","volume":"133","author":"H Sun","year":"2016","unstructured":"un, H., Olson, K. C., Gao, C., Prosdocimo, D. A., Zhou, M., Wang, Z., Jeyaraj, D., Youn, J.-Y., Ren, S., Liu, Y., Rau, C. D., Shah, S., Ilkayeva, O., Gui, W.-J., William, N. S., Wynn, R. M., Newgard, C. B., Cai, H., Xiao, X., \u2026 Wang, Y. (2016). Catabolic defect of branched-chain amino acids promotes heart failure. Circulation, 133(21), 2038\u20132049. https:\/\/doi.org\/10.1161\/circulationaha.115.020226","journal-title":"Circulation"},{"issue":"7","key":"10079_CR126","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1194\/jlr.d082370","volume":"59","author":"M Sch\u00f6nke","year":"2018","unstructured":"Sch\u00f6nke, M., Massart, J., & Zierath, J. R. (2018). Effects of high-fat diet and AMP-activated protein kinase modulation on the regulation of whole-body lipid metabolism. Journal of Lipid Research, 59(7), 1276\u20131282. https:\/\/doi.org\/10.1194\/jlr.d082370","journal-title":"Journal of Lipid Research"},{"issue":"5","key":"10079_CR127","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nm.3159","volume":"19","author":"M Ahmadian","year":"2013","unstructured":"Ahmadian, M., Suh, J. M., Hah, N., Liddle, C., Atkins, A. R., Downes, M., & Evans, R. M. (2013). PPAR\u03b3 signaling and metabolism: The good, the bad and the future. Nature Medicine, 19(5), 557\u2013566. https:\/\/doi.org\/10.1038\/nm.3159","journal-title":"Nature Medicine"},{"issue":"12","key":"10079_CR128","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1038\/s42255-022-00689-4","volume":"4","author":"M Patrick","year":"2022","unstructured":"Patrick, M., Gu, Z., Zhang, G., Wynn, R. M., Kaphle, P., Cao, H., Vu, H., Cai, F., Gao, X., Zhang, Y., Chen, M., Ni, M., Chuang, D. T., DeBerardinis, R. J., & Xu, J. (2022). Metabolon formation regulates branched-chain amino acid oxidation and homeostasis. Nature Metabolism, 4(12), 1775\u20131791. https:\/\/doi.org\/10.1038\/s42255-022-00689-4","journal-title":"Nature Metabolism"},{"issue":"4","key":"10079_CR129","doi-asserted-by":"publisher","first-page":"954","DOI":"10.3390\/ijms19040954","volume":"19","author":"C Nie","year":"2018","unstructured":"Nie, C., He, T., Zhang, W., Zhang, G., & Ma, X. (2018). Branched chain amino acids: Beyond nutrition metabolism. International Journal of Molecular Sciences, 19(4), 954. https:\/\/doi.org\/10.3390\/ijms19040954","journal-title":"International Journal of Molecular Sciences"},{"issue":"9","key":"10079_CR130","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1172\/jci120849","volume":"128","author":"B Zhou","year":"2018","unstructured":"Zhou, B., & Tian, R. (2018). Mitochondrial dysfunction in pathophysiology of heart failure. Journal of Clinical Investigation, 128(9), 3716\u20133726. https:\/\/doi.org\/10.1172\/jci120849","journal-title":"Journal of Clinical Investigation"},{"key":"10079_CR131","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.647481","author":"Y Yang","year":"2021","unstructured":"Yang, Y., Zhao, M., He, X., Wu, Q., Li, D.-L., & Zang, W.-J. (2021). Pyridostigmine protects against diabetic cardiomyopathy by regulating vagal activity, gut microbiota, and branched-chain amino acid catabolism in diabetic mice. Frontiers in Pharmacology. https:\/\/doi.org\/10.3389\/fphar.2021.647481","journal-title":"Frontiers in Pharmacology"},{"key":"10079_CR132","doi-asserted-by":"crossref","unstructured":"Xu, T., Brandmaier, S., Messias, A. C., Herder, C., Draisma, H. H. M., Demirkan, A., Yu, Z., Ried, J. S., Haller, T., Heier, M., Campillos, M., Fobo, G., Stark, R., Holzapfel, C., Adam, J., Chi, S., Rotter, M., Panni, T., Quante, A. S., \u2026 Wang-Sattler, R. (2015). Effects of metformin on metabolite profiles and LDL cholesterol in patients with type 2 diabetes, https:\/\/pubmed.ncbi.nlm.nih.gov\/26251408\/","DOI":"10.2337\/dc15-0658"},{"issue":"1","key":"10079_CR133","first-page":"1008","volume":"1","author":"KA Coughlan","year":"2013","unstructured":"Coughlan, K. A., Valentine, R. J., Ruderman, N. B., & Saha, A. K. (2013). Nutrient excess in AMPK downregulation and insulin resistance. Journal of Endocrinology, Diabetes & Obesity, 1(1), 1008.","journal-title":"Journal of Endocrinology, Diabetes & Obesity"},{"issue":"5","key":"10079_CR134","doi-asserted-by":"publisher","first-page":"3914","DOI":"10.3390\/nu7053914","volume":"7","author":"JAB Pedroso","year":"2015","unstructured":"Pedroso, J. A. B., Zampieri, T. T., & Donato, J. (2015). Reviewing the effects of l-Leucine supplementation in the regulation of food intake, energy balance, and glucose homeostasis. Nutrients, 7(5), 3914\u20133937. https:\/\/doi.org\/10.3390\/nu7053914","journal-title":"Nutrients"},{"key":"10079_CR135","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/239750","volume":"2014","author":"C Liang","year":"2014","unstructured":"Liang, C., Curry, B. J., Brown, P. L., & Zemel, M. B. (2014). Leucine modulates mitochondrial biogenesis and SIRT1-AMPK signaling in C2C12 myotubes. Journal of Nutrition and Metabolism, 2014, 1\u201311. https:\/\/doi.org\/10.1155\/2014\/239750","journal-title":"Journal of Nutrition and Metabolism"},{"key":"10079_CR136","doi-asserted-by":"publisher","DOI":"10.1186\/s12986-021-00564-1","author":"Z Zhou","year":"2021","unstructured":"Zhou, Z., Yin, H., Guo, Y., Fang, Y., Yuan, F., Chen, S., & Guo, F. (2021). A fifty percent leucine-restricted diet reduces fat mass and improves glucose regulation. Nutrition & Metabolism (London). https:\/\/doi.org\/10.1186\/s12986-021-00564-1","journal-title":"Nutrition & Metabolism (London)"},{"issue":"3","key":"10079_CR137","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s43587-022-00180-5","volume":"2","author":"H Chen","year":"2022","unstructured":"Chen, H., Shen, J., Xuan, J., Zhu, A., Ji, J. S., Liu, X., Cao, Y., Zong, G., Zeng, Y., Wang, X., & Yuan, C. (2022). Plant-based dietary patterns in relation to mortality among older adults in China. Nature Aging, 2(3), 224\u2013230. https:\/\/doi.org\/10.1038\/s43587-022-00180-5","journal-title":"Nature Aging"},{"issue":"9","key":"10079_CR138","doi-asserted-by":"publisher","first-page":"e00830","DOI":"10.1016\/j.heliyon.2018.e00830","volume":"4","author":"S Wei","year":"2018","unstructured":"Wei, S., Zhao, J., Wang, S., Huang, M., Wang, Y., & Chen, Y. (2018). Intermittent administration of a leucine-deprived diet is able to intervene in type 2 diabetes in db\/db mice. Heliyon, 4(9), e00830\u2013e00830. https:\/\/doi.org\/10.1016\/j.heliyon.2018.e00830","journal-title":"Heliyon"},{"issue":"7","key":"10079_CR139","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1111\/cas.16191","volume":"115","author":"S Saito","year":"2024","unstructured":"Saito, S., Ando, K., Sakamoto, S., Xu, M., Yamada, Y., Rii, J., Kanaoka, S., Wei, J., Zhao, X., Pae, S., Kanesaka, M., Goto, Y., Sazuka, T., Imamura, Y., Reien, Y., Hamaguchi\u2010Suzuki, N., Saito, S., Hirayama, Y., Hashimoto, H., \u2026 Anzai, N. (2024). The\u2009LAT1\u2009Inhibitor\u2009JPH203\u2009Suppresses the growth of Castration-resistant prostate cancer through a\u2009 \u2009CD24\u2010mediated mechanism. Cancer Science, 115(7), 2461\u20132472. https:\/\/doi.org\/10.1111\/cas.16191","journal-title":"Cancer Science"},{"issue":"1","key":"10079_CR140","doi-asserted-by":"publisher","first-page":"16776","DOI":"10.1038\/s41598-019-53397-7","volume":"9","author":"K Higuchi","year":"2019","unstructured":"Higuchi, K., Sakamoto, S., Ando, K., Maimaiti, M., Takeshita, N., Okunushi, K., Reien, Y., Imamura, Y., Sazuka, T., Nakamura, K., Matsushima, J., Furihata, T., Ikehara, Y., Ichikawa, T., & Anzai, N. (2019). Characterization of the expression of LAT1 as a prognostic indicator and a therapeutic target in renal cell carcinoma. Scientific Reports, 9(1), 16776. https:\/\/doi.org\/10.1038\/s41598-019-53397-7","journal-title":"Scientific Reports"},{"key":"10079_CR141","doi-asserted-by":"publisher","DOI":"10.1186\/s40170-022-00295-8","author":"H Okanishi","year":"2022","unstructured":"Okanishi, H., Ohgaki, R., Xu, M., Endou, H., & Kanai, Y. (2022). Phosphoproteomics revealed cellular signals immediately responding to disruption of cancer amino acid homeostasis induced by inhibition of l-type amino acid transporter 1. Cancer Metabolism. https:\/\/doi.org\/10.1186\/s40170-022-00295-8","journal-title":"Cancer Metabolism"},{"issue":"9","key":"10079_CR142","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1038\/s12276-023-01081-2","volume":"55","author":"D Liu","year":"2023","unstructured":"Liu, D., Xing, R., Zhang, Q., Tian, X., Qi, Y., Song, H., Liu, Y., Yu, H., Zhang, X., Jing, Q., Yan, C., & Han, Y.(2023). The CREG1-FBXO27-LAMP2 axis alleviates diabetic cardiomyopathy by promoting autophagy in cardiomyocytes. Experimental & Molecular Medicine, 55(9), 2025\u20132038. https:\/\/doi.org\/10.1038\/s12276-023-01081-2","journal-title":"Experimental & Molecular Medicine"},{"key":"10079_CR143","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yjmcc.2020.09.003","volume":"149","author":"J Mu","year":"2020","unstructured":"Mu, J., Zhang, D., Tian, Y., Xie, Z., & Zou, M.-H. (2020). BRD4 inhibition by JQ1 prevents high-fat diet-induced diabetic cardiomyopathy by activating PINK1\/Parkin-mediated mitophagy in vivo. Journal of Molecular and Cellular Cardiology, 149, 1\u201314. https:\/\/doi.org\/10.1016\/j.yjmcc.2020.09.003","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"2","key":"10079_CR144","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/cas.13908","volume":"110","author":"S Ueda","year":"2019","unstructured":"Ueda, S., Hayashi, H., Miyamoto, T., Abe, S., Hirai, K., Matsukura, K., Yagi, H., Hara, Y., Yoshida, K., Okazaki, S., Tamura, M., Abe, Y., Agatsuma, T., Niwa, S., Masuko, K., & Masuko, T. (2019). Anti-tumor effects of mAb against \u2009l\u2010type amino acid transporter 1 (LAT\u20091) bound to human and Monkey\u2009\u2009LAT\u20091 with dual avidity modes. Cancer Science, 110(2), 674\u2013685. https:\/\/doi.org\/10.1111\/cas.13908","journal-title":"Cancer Science"},{"issue":"3","key":"10079_CR145","doi-asserted-by":"publisher","first-page":"C866","DOI":"10.1152\/ajpcell.00537.2023","volume":"326","author":"S Mora","year":"2024","unstructured":"Mora, S., & Adegoke, O. A. J. (2024). Maintenance of the branched-chain amino acid transporter LAT1 counteracts myotube atrophy following chemotherapy. American Journal of Physiology-Cell Physiology, 326(3), C866\u2013C879.","journal-title":"American Journal of Physiology-Cell Physiology"},{"key":"10079_CR146","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.exppara.2015.01.003","volume":"150","author":"S Su","year":"2015","unstructured":"Su, S., Miska, K. B., Fetterer, R. H., Jenkins, M. C., & Wong, E. A. (2015). Expression of digestive enzymes and nutrient transporters in Eimeria-challenged broilers. Experimental Parasitology, 150, 13\u201321.","journal-title":"Experimental Parasitology"},{"issue":"9","key":"10079_CR147","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1038\/jcbfm.2009.72","volume":"29","author":"R Lyck","year":"2009","unstructured":"Lyck, R., Ruderisch, N., Moll, A. G., Steiner, O., Cohen, C. D., Engelhardt, B., Makrides, V., & Verrey, F. (2009). Culture-induced changes in blood\u2014brain barrier transcriptome: Implications for amino-acid transporters in vivo. Journal of Cerebral Blood Flow & Metabolism, 29(9), 1491\u20131502.","journal-title":"Journal of Cerebral Blood Flow & Metabolism"},{"key":"10079_CR148","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-025-02570-8","author":"KB Travis","year":"2025","unstructured":"Travis, K. B., Ragland, K. J., Spry, E. R., Zaman, T., Lundin, P. M., & Vaughan, R. A. (2025). The L-type amino acid transporter inhibitor, BCH, inhibits myotube BCAA uptake and mitochondrial function without altering myotube insulin sensitivity during insulin resistance in C2C12 myotubes. Acta Diabetologica. https:\/\/doi.org\/10.1007\/s00592-025-02570-8","journal-title":"Acta Diabetologica"},{"key":"10079_CR149","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-024-01872-3","author":"H Zheng","year":"2024","unstructured":"Zheng, H., Zhang, X., Li, C., Wang, D., Shen, Y., Lu, J., Zhao, L., Li, X., & Gao, H. (2024). BCAA mediated microbiota-liver-heart crosstalk regulates diabetic cardiomyopathy via FGF21. Microbiome. https:\/\/doi.org\/10.1186\/s40168-024-01872-3","journal-title":"Microbiome"},{"issue":"10","key":"10079_CR150","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.3390\/biom11101414","volume":"11","author":"J Gojda","year":"2021","unstructured":"Gojda, J., & Cahova, M. (2021). Gut microbiota as the link between elevated BCAA serum levels and insulin resistance. Biomolecules, 11(10), 1414.","journal-title":"Biomolecules"},{"issue":"3","key":"10079_CR151","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3390\/cells9030693","volume":"9","author":"I Lamiquiz-Moneo","year":"2020","unstructured":"Lamiquiz-Moneo, I., Bea, A. M., Palacios-P\u00e9rez, C., Miguel-Etayo, P. De, Gonz\u00e1lez-Gil, E. M., L\u00f3pez-Ari\u00f1o, C., Civeira, F., Moreno, L. A., & Mateo-Gallego, R. (2020). Effect of lifestyle intervention in the concentration of adipoquines and branched chain amino acids in subjects with high risk of developing type 2 diabetes: Feel4Diabetes study. Cells, 9(3), 693. https:\/\/doi.org\/10.3390\/cells9030693","journal-title":"Cells"},{"issue":"7","key":"10079_CR152","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.3390\/nu15071713","volume":"15","author":"H Shah","year":"2023","unstructured":"Shah, H., Kramer, A., Mullins, C. A., Mattern, M., Gannaban, R. B., Townsend, R. L., Campagna, S. R., Morrison, C. D., Berthoud, H.-R., & Shin, A. C. (2023). Reduction of plasma BCAAs following Roux-en-Y gastric bypass surgery is primarily mediated by FGF21. Nutrients, 15(7), 1713. https:\/\/doi.org\/10.3390\/nu15071713","journal-title":"Nutrients"},{"issue":"30","key":"10079_CR153","doi-asserted-by":"publisher","first-page":"10984","DOI":"10.12998\/wjcc.v10.i30.10984","volume":"10","author":"JY Du","year":"2022","unstructured":"Du, J. Y., Shu, L., Zhou, Y. T., & Zhang, L. (2022). Branched-chain amino acids supplementation has beneficial effects on the progression of liver cirrhosis: A meta-analysis. World Journal of Clinical Cases, 10(30), 10984\u201310996. https:\/\/doi.org\/10.12998\/wjcc.v10.i30.10984","journal-title":"World Journal of Clinical Cases"},{"key":"10079_CR154","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac463","author":"J Kivel\u00e4","year":"2022","unstructured":"Kivel\u00e4, J., Meinil\u00e4, J., Uusitupa, M., Tuomilehto, J., & Lindstr\u00f6m, J. (2022). Longitudinal branched-chain amino acids, lifestyle intervention and type 2 diabetes in Finnish diabetes prevention study. Journal of Clinical Endocrinology and Metabolism. https:\/\/doi.org\/10.1210\/clinem\/dgac463","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"1","key":"10079_CR155","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1080\/07853890.2021.1965204","volume":"53","author":"W Hu","year":"2021","unstructured":"Hu, W., Liu, Z., Yu, W., Wen, S., Wang, X., Qi, X., Hao, H., Lu, Y., Li, J., Li, S., & Zhou, H. (2021). Effects of PPM1Krs1440581 and rs7678928 on serum branched-chain amino acid levels and risk of cardiovascular disease. Annals of Medicine, 53(1), 1317\u20131327. https:\/\/doi.org\/10.1080\/07853890.2021.1965204","journal-title":"Annals of Medicine"},{"issue":"11","key":"10079_CR156","doi-asserted-by":"publisher","first-page":"3210","DOI":"10.1016\/j.numecd.2021.07.011","volume":"31","author":"JM Vargas-Morales","year":"2021","unstructured":"Vargas-Morales, J. M., Guizar-Heredia, R., M\u00e9ndez-Garc\\\u2019\\ia, A. L., Palacios-Gonzalez, B., Schcolnik-Cabrera, A., Granados, O., L\u00f3pez-Barradas, A. M., V\u00e1zquez-Manjarrez, N., Medina-Vera, I., Aguilar-L\u00f3pez, M., & others. (2021). Association of BCAT2 and BCKDH polymorphisms with clinical, anthropometric and biochemical parameters in young adults. Nutrition, Metabolism, and Cardiovascular Diseases\u202f: NMCD, 31(11), 3210\u20133218.","journal-title":"Nutrition, Metabolism, and Cardiovascular Diseases : NMCD"},{"issue":"2","key":"10079_CR157","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41569-022-00760-3","volume":"20","author":"RW McGarrah","year":"2023","unstructured":"McGarrah, R. W., & White, P. J. (2023). Branched-chain amino acids in cardiovascular disease. Nature Reviews. Cardiology, 20(2), 77\u201389.","journal-title":"Nature Reviews. Cardiology"},{"issue":"1","key":"10079_CR158","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-023-00510-4","volume":"28","author":"Q-B Lu","year":"2023","unstructured":"Lu, Q.-B., Fu, X., Liu, Y., Wang, Z.-C., Liu, S.-Y., Li, Y.-C., & Sun, H.-J. (2023). Disrupted cardiac fibroblast BCAA catabolism contributes to diabetic cardiomyopathy via a periostin\/NAP1L2\/SIRT3 axis. Cellular & Molecular Biology Letters, 28(1), Article 93.","journal-title":"Cellular & Molecular Biology Letters"},{"key":"10079_CR159","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202101030","author":"M Bao","year":"2022","unstructured":"Bao, M., Hou, K., Xin, C., Zeng, D., Cheng, C., Zhao, H., Wang, Z., & Wang, L. (2022). Portulaca oleraceaL. extract alleviated type 2 diabetes via modulating the gut microbiota and serum branched-chain amino acid metabolism. Molecular Nutrition & Food Research. https:\/\/doi.org\/10.1002\/mnfr.202101030","journal-title":"Molecular Nutrition & Food Research"},{"issue":"9","key":"10079_CR160","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.63.9.7","volume":"63","author":"S Iwai","year":"2022","unstructured":"Iwai, S., Hasegawa, T., Ikeda, H. O., & Tsujikawa, A. (2022). Branched chain amino acids promote ATP production via translocation of glucose transporters. Investigative Ophthalmology & Visual Science, 63(9), Article 7. https:\/\/doi.org\/10.1167\/iovs.63.9.7","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"4","key":"10079_CR161","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/wsbm.1219","volume":"5","author":"JSA Mattick","year":"2013","unstructured":"Mattick, J. S. A., Kamisoglu, K., Ierapetritou, M. G., Androulakis, I. P., & Berthiaume, F. (2013). Branched-chain amino acid supplementation: Impact on signaling and relevance to critical illness. Wiley Interdisciplinary Reviews. Systems Biology and Medicine, 5(4), 449\u2013460. https:\/\/doi.org\/10.1002\/wsbm.1219","journal-title":"Wiley Interdisciplinary Reviews. Systems Biology and Medicine"},{"issue":"2","key":"10079_CR162","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.phanu.2018.01.003","volume":"6","author":"R A.","year":"2018","unstructured":"A., R., Agrawal, N., Kumar, H., & Kumar, V. (2018). Emerging role of branched chain amino acids in metabolic disorders: A mechanistic review. PharmaNutrition, 6(2), 47\u201354. https:\/\/doi.org\/10.1016\/j.phanu.2018.01.003","journal-title":"PharmaNutrition"},{"key":"10079_CR163","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.118.011625","author":"M Chen","year":"2019","unstructured":"Chen, M., Gao, C., Yu, J., Ren, S., Wang, M., Wynn, R. M., Chuang, D. T., Wang, Y., & Sun, H.(2019). Therapeutic effect of targeting branched-chain amino acid catabolic flux in pressure\u2010overload induced heart failure. Journal of the American Heart Association. https:\/\/doi.org\/10.1161\/jaha.118.011625","journal-title":"Journal of the American Heart Association"},{"issue":"19","key":"10079_CR164","doi-asserted-by":"publisher","first-page":"7333","DOI":"10.7150\/thno.102708","volume":"14","author":"ZY Zhou","year":"2024","unstructured":"Zhou, Z.-Y., Song, K., Liu, Z.-Y., Ke, Y.-F., Shi, Y., Cai, K., Zhao, R., Sun, X., Tao, H., & Zhao, J.-Y. (2024). Branched-chain amino acids deficiency promotes diabetic cardiomyopathy by activating autophagy of cardiac fibroblasts. Theranostics, 14(19), 7333.","journal-title":"Theranostics"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-025-10079-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12012-025-10079-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-025-10079-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T05:04:14Z","timestamp":1769231054000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12012-025-10079-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":164,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10079"],"URL":"https:\/\/doi.org\/10.1007\/s12012-025-10079-3","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]},"assertion":[{"value":"11 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no financial or non-financial conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"8"}}